Evidence map›Paper›PMID 37428986›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Reply to M. Roach et al and K.H. Stopsack et al.

Andrew J Vickers, Brandon Mahal, Olorunseun O Ogunwobi

Abstract readLetterComment
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Andrew J VickersAndrew J. Vickers, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; Brandon Mahal, MD, Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Olorunseun O. Ogunwobi, MBBS, PhD, Hunter College Center for Cancer Health Disparities Research, Hunter College, City University of New York, NY.ORCID 0000-0003-1525-6503
Brandon MahalAndrew J. Vickers, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; Brandon Mahal, MD, Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Olorunseun O. Ogunwobi, MBBS, PhD, Hunter College Center for Cancer Health Disparities Research, Hunter College, City University of New York, NY.
Olorunseun O OgunwobiAndrew J. Vickers, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; Brandon Mahal, MD, Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Olorunseun O. Ogunwobi, MBBS, PhD, Hunter College Center for Cancer Health Disparities Research, Hunter College, City University of New York, NY.ORCID 0000-0003-3388-2137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Humans

Identifiers

PMID37428986
PMCPMC10553044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.